Abstract
Lymph node assessment improves staging and results in better overall survival in surgically treated lung cancer patients. Routinely, the hilar and intrapulmonary lymph nodes are collected by the pathologist in surgical specimens after surgical treatment of lung cancer. Our hypothesis is that the dissection and identification of hilar and intrapulmonary lymph nodes performed by the surgeon results in greater lymph node sampling than the same dissection performed by pathologist.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
